Skip to main content
Clinical Trials/NCT03315598
NCT03315598CompletedNot Applicable

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain: An Open-labeled, Single-arm, Exploratory Pilot Study

Seoul National University1 site in 1 country22 target enrollmentStarted: May 15, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
1
Primary Endpoint
Change from baseline Numeric rating scale pain score (0-10) at 8 weeks

Study Overview

Brief Summary

The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.

Detailed Description

The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome.

  • Postherpetic neuralgia
  • Failed back surgery syndrome
  • Diabetic neuropathy
  • other peripheral neuropathy

Patients with refractory neuropathic pain who do not respond to conservative treatment for more than 3 months should be included. Acupuncture treatment is maintained for 2 months in oriental medicine hospital. The effect is evaluated through the numeric rating score and the validated questionnaire.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients who can adequately write a reportable questionnaire
  • •Patients who have been diagnosed with one of the following neuropathic pain disease (postherpetic neuralgia, failed back surgery syndrome, diabetic neuropathy, other peripheral neuropathy)
  • •Patients who failed conservative treatment at Seoul National University Hospital for more than 3 months.
  • •Patients with NRS 5 points or more
  • •Patients with painDETECT score 19 points or more

Exclusion Criteria

  • •Patients with major mental illness
  • •Patients with unstable medical conditions
  • •Patients who received acupuncture treatment at the site within the past month
  • •Patients with bleeding tendency
  • •Patients taking immunosuppressive drugs

Arms & Interventions

An open-labeled, single-arm, exploratory pilot study

Experimental

Electroacupunture for 2months

Intervention: Electroacupuncture (Procedure)

Outcomes

Primary Outcomes

Change from baseline Numeric rating scale pain score (0-10) at 8 weeks

Time Frame: At 8-week follow-up visit

The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).

Change from baseline Numeric rating scale pain score (0-10) at 4 weeks

Time Frame: At 4-week follow-up visit

The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).

Secondary Outcomes

  • Change from the score of the short-form McGill Pain Questionnaire at 8 weeks(At 8-week follow-up visit)
  • Change from baseline score of Brief Pain Inventory Short Form (BFI-SF) at 8 weeks(At 8-week follow-up visit)
  • 5-pointed patient satisfaction scale(At 8-week follow-up visit)
  • Patients' Global Impression of Change (PGIC) scale(At 8-week follow-up visit)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeeyoun Moon

Associate professor

Seoul National University

Study Sites (1)

Loading locations...

Similar Trials